Pharmaceutical preparations, namely, drugs for the treatment of cancer, inflammatory muscle and connective tissue diseases, neurodegenerative diseases, respiratory diseases, and viral diseases, all the foregoing relating to cell proliferation in humans
REGISTERED
on 31 Oct 2019
OREXPANT
KARYOPHARM THERAPEUTICS INC.
1878127 · 18 Jan 2018
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations, namely, drugs for the treatment of cancer, inflammatory muscle and connective tissue diseases, neurodegenerative diseases, respiratory diseases, and viral diseases, all the foregoing relating to cell proliferation in humans
Pharmaceutical preparations, namely, drugs for the treatment of cancer...
